PharmEasy halves loss to Rs 2,533 crore in FY24, revenue dips 15%

16 hours ago · Mumbai-based PharmEasy, operated by API Holdings Limited, reported a net loss of Rs 2,533 crore, an improvement from the Rs 5,212 crore loss in FY23, driven by a reduction …

CouponFollow Extension

15%
OFF

PharmEasy Halves Loss To Rs 2,533 Crore In FY24, Revenue Dips 15%

1 week from now

16 hours ago · Mumbai-based PharmEasy, operated by API Holdings Limited, reported a net loss of Rs 2,533 crore, an improvement from the Rs 5,212 crore loss in FY23, driven by a reduction …

indiatimes.com

16%
OFF

PharmEasy Valuation Slashed To $458 Mn By Janus Henderson

1 week from now

Sep 3, 2024 · PharmEasy’s investor and global asset management company Janus Henderson slashes the ... the firm posted a 16% year-on-year growth to Rs 6,643 crore revenue in FY23 …

entrackr.com

41%
OFF

PharmEasy Biggest Underperformer In Prosus’ India Portfolio In …

1 week from now

Nov 29, 2023 · PharmEasy had an IRR of -41% in H1 FY24, as per data released by Prosus in its half yearly financial statements ... Overall, the investment major’s operating loss rose to $415 …

inc42.com

$1.78
OFF

PharmEasy Stock Price, Funding, Valuation, Revenue & Financial …

1 week from now

Funding, Valuation & Revenue. 16 Fundings. PharmEasy has raised $1.785B over 16 rounds.. PharmEasy's latest funding round was a Series G - II for $216M on April 29, 2024.. …

cbinsights.com

50%
OFF

Janus Henderson Cuts PharmEasy’s Valuation By 50% - Entrackr

1 week from now

May 15, 2023 · Its investor and global asset management company Janus Henderson has reduced the unicorn’s valuation by nearly 50%. ... PharmEasy’s gross revenue spiked 2.5X to …

entrackr.com

27%
OFF

Bergen County NJ 2024 Budget: What It Means For Taxpayers

1 week from now

Mar 21, 2024 · HACKENSACK — Bergen County's 2024 budget will increase by 2.27% over the current one, which means the tax bill for the average assessed home of $530,000 will see an …

northjersey.com

$216
OFF

Exclusive: PharmEasy Raises $216 Mn Led By MEMG At $710 Mn

1 week from now

Apr 29, 2024 · PharmEasy has raised Rs 1,804 crore ($216 million) led by Ranjan Pai's Manipal Education and Medical Group (MEMG) and existing investors. ... the company has been …

entrackr.com

FAQs about PharmEasy halves loss to Rs 2,533 crore in FY24, revenue dips 15% Coupon?

How did PharmEasy perform in fy24?

Sales of medicines (goods) for FY24 were Rs 5,008 crore, while revenue from lab tests and other services stood at Rs 652 crore. PharmEasy published these numbers on its website. Total expenses for the year were Rs 7,255 crore, reflecting a reduction from Rs 8,974 crore in the previous year, but remaining significant in comparison to revenue. ...

How did PharmEasy's revenue grow in the last fiscal year?

For now, let’s focus on its revenue which grew 2.5X in the last fiscal year. PharmEasy’s revenue from operations grew to Rs 5,729 crore during the fiscal year ending March 2022 as opposed to Rs 2,335 crore in FY21, according to its annual financial statements with the RoC. ...

What is the Profit & Loss Statement for fy24?

The Profit and Loss statement for FY24 reflects a significant reduction in losses compared to FY23: Loss Before Exceptional Items and Tax: Reduced from INR 2274 Cr in FY23 to INR 1494 Cr in FY24. Loss for the Year: Reduced from INR 5211 Cr in FY23 to INR 2533 Cr in FY24. ...

How has PharmEasy performed in fiscal year 2024?

Introduction PharmEasy, a leading digital healthcare platform in India, has made significant strides in optimizing its operations and focusing on higher-margin segments. The fiscal year 2024 (FY24) has been a challenging yet transformative year for the company. ...

What was PharmEasy's Gross Merchandise Value in FY23?

PharmEasy’s gross merchandise value (GMV), however, stood at Rs 14,351 crore in FY23. API Holdings operates in diversified sectors, primarily engaging in the trading of pharmaceutical and cosmetic goods. This core activity constitutes approximately 90% of the company's revenue. ...

What was PharmEasy's revenue in 2023?

PharmEasy's 2023 revenue was $795.96M. PharmEasy's most recent revenue is from 2022. Sign up for a free demo to see revenue data from 2022 and more. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. ...